187 related articles for article (PubMed ID: 34013554)
1. Screening for second malignancies in mycosis fungoides: non-Hodgkin lymphoma, Hodgkin lymphoma, lung cancer, bladder cancer and melanoma.
Goyal A; O'Leary D; Goyal K; Rubin N; Janakiram M
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):1821-1829. PubMed ID: 34013554
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer.
Goyal A; O'Leary D; Goyal K; Patel K; Pearson D; Janakiram M
J Am Acad Dermatol; 2021 Dec; 85(6):1418-1428. PubMed ID: 32822803
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of second primary hematologic and solid malignancies in patients with mycosis fungoides: A Surveillance, Epidemiology, and End Results analysis.
Goyal A; O'Leary D; Goyal K; Rubin N; Bohjanen K; Hordinsky M; Chen ST; Pongas G; Duncan LM; Lazaryan A
J Am Acad Dermatol; 2020 Aug; 83(2):404-411. PubMed ID: 31374302
[TBL] [Abstract][Full Text] [Related]
4. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
[TBL] [Abstract][Full Text] [Related]
5. Mycosis fungoides with large cell transformation (CD30+) and B-cell chronic lymphocytic leukemia.
Petković M; Ilić I; Jurakić Tončić R; Radman-Livaja I; Čeović R
Acta Dermatovenerol Croat; 2023 Dec; 31(4):223-224. PubMed ID: 38651850
[TBL] [Abstract][Full Text] [Related]
6. Outcomes after diagnosis of mycosis fungoides and Sézary syndrome before 30 years of age: a population-based study.
Ai WZ; Keegan TH; Press DJ; Yang J; Pincus LB; Kim YH; Chang ET
JAMA Dermatol; 2014 Jul; 150(7):709-15. PubMed ID: 24718769
[TBL] [Abstract][Full Text] [Related]
7. Mycosis fungoides associated with malignant melanoma and dysplastic nevus syndrome.
Pielop JA; Brownell I; Duvic M
Int J Dermatol; 2003 Feb; 42(2):116-22. PubMed ID: 12708999
[TBL] [Abstract][Full Text] [Related]
8. Metachronous primary melanoma and lymphoma.
McIntosh BC; Ariyan S; Esche G; Zelterman D; Narayan D
Ann Plast Surg; 2010 Feb; 64(2):229-32. PubMed ID: 20098111
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
[TBL] [Abstract][Full Text] [Related]
10. Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A Surveillance, Epidemiology, and End Results database analysis.
Banner L; Rohan TZ; Zachian R; Gross T; Yang HY; Joffe D; Porcu P; Nikbakht N
J Am Acad Dermatol; 2024 Jul; 91(1):151-153. PubMed ID: 38513830
[No Abstract] [Full Text] [Related]
11. Melanoma Risk is Increased in Patients with Mycosis Fungoides Compared with Patients with Psoriasis and the General Population.
Sherman S; Kremer N; Dalal A; Solomon-Cohen E; Berkovich E; Noyman Y; Ben-Lassan M; Levi A; Pavlovsky L; Prag Naveh H; Hodak E; Amitay-Laish I
Acta Derm Venereol; 2020 Dec; 100(19):adv00346. PubMed ID: 33241425
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of secondary malignancies in a large series of mycosis fungoides.
Atci T; Yerlioğlu Ak D; Baykal C
An Bras Dermatol; 2024; 99(3):370-379. PubMed ID: 38262820
[TBL] [Abstract][Full Text] [Related]
13. Mycosis fungoides associated with B-cell malignancies.
Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
[TBL] [Abstract][Full Text] [Related]
14. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
[TBL] [Abstract][Full Text] [Related]
15. New insights into associated co-morbidities in patients with cutaneous T-cell lymphoma (mycosis fungoides).
Hodak E; Lessin S; Friedland R; Freud T; David M; Pavlovsky L; Shapiro J; Cohen AD
Acta Derm Venereol; 2013 Jul; 93(4):451-5. PubMed ID: 23303582
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematous and malignancy risk: a meta-analysis.
Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
[TBL] [Abstract][Full Text] [Related]
17. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype.
Amber KT; Bloom R; Nouri K
Am J Clin Dermatol; 2016 Feb; 17(1):71-7. PubMed ID: 26386881
[TBL] [Abstract][Full Text] [Related]
18. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous composite lymphoma of mycosis fungoides and Hodgkin lymphoma: Response to sequential therapy.
Chen Y; Nong L; Li X; Wang Y
J Cutan Pathol; 2020 Sep; 47(9):829-833. PubMed ID: 32285466
[TBL] [Abstract][Full Text] [Related]
20. Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy.
Pulte D; Gondos A; Brenner H
Leuk Lymphoma; 2009 Feb; 50(2):179-86. PubMed ID: 19197735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
